Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise

Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity fin...
Streetwise Reports | January 6, 2020 |

Alpine Immune Shares Soar 160% on Global Option and License Agreement with AbbVie

Shares of Alpine Immune Sciences set a new 52-week high after the company reported that it entered into an exclusive worldwide option and license agreement with AbbVie Inc. to develop and commercialize ALPN-101. Clinical-stage immunotherapy company Alpine Immune S...
Streetwise Reports | June 19, 2020 |

Royalties Face Mine Problems and Tax Bills

Royal Gold Inc. (RGLD:NASDAQ; RGL:TSX, US$115.82) (115.82) is facing uncertainty on its main asset, the Mount Milligan copper-gold mine in British Columbia, whose stream accounts for nearly 30% of the company's revenue and its book value. The mine has experienced lower...
Streetwise Reports | December 20, 2019 |

Adrian Day: Stay with the Royalties in a Bull Market

Money manager Adrian Day explains why he is a believer in holding royalty company shares in a bull market. There is a common perception that the royalty—and streaming—companies are defensive in a bear market, but that you don't want to own them in a bull market since ...
Streetwise Reports | August 22, 2019 |

Mostly Strong Results from Majors as Gold Zooms

With a higher gold price (in the fourth quarter) than in the same quarter a year ago, results have been generally positive. But last week's jump in the gold price on concerns about coronavirus have taken many gold stocks to short-term overvalued levels and made them vulne...
Streetwise Reports | February 28, 2020 |

This Next-Gen Battery Element Can Store More Lithium than Graphite

(Image via NEO Battery Materials Ltd.) There have been major advancement s made in recent years to power, for longer periods of time, the growing number of portable electronics in our lives, as well as hybrid and full electric vehicles (EVs)…. However,...
Stockhouse Editorial | September 9, 2021 |

World's major gold miners target copper porphyries

Something has changed in the gold industry. During high gold-price periods the trend was to produce as much as possible - in many cases, irrespective of higher extraction costs per ounce. In a way you can’t blame them for making hay while the sun shone. The g...
Richard (Rick) Mills | November 8, 2019 |